Drug intelligence / Profile preview

liposomal curcumin

Development stage
Phase 4
Lead developer
SignPath Pharma
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Oral, Intravenous
01

Overview

Liposomal curcumin is a formulation in which the active compound, curcumin—a polyphenol derived from the root of *Curcuma longa* (turmeric)—is encapsulated within phospholipid-based vesicles called liposomes. This delivery system significantly enhances the bioavailability and absorption of otherwise poorly water-soluble and rapidly metabolized free-form curcumin. Mechanistically, curcumin exhibits antineoplastic, chemopreventive, antioxidant, anti-angiogenic, and anti-inflammatory activities. It modulates multiple molecular targets involved in inflammation and cancer progression by inhibiting nuclear factor kappa B (NF-κB) signaling pathways and downregulating pro-inflammatory cytokines. Preclinical studies have shown tumor growth reduction in pancreatic and colorectal cancers; clinical trials are ongoing for high-grade gliomas[1][6][8]. The improved pharmacokinetics of the liposomal form allow for both oral and intravenous administration with enhanced systemic exposure compared to standard extracts.

Brand names
Liposomal CurcuminLiposomal Curcumin (Amy Myers MD)Liposomal Curcumin (NutriDyn)Liposomal Curcumin (NuMedica)
Other names
liposome-encapsulated curcuminmicelle curcuminliquid liposomal curcumin
02

Targets

NFKB1 (NF-κB1)

Beyond the preview

Go deeper on liposomal curcumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on liposomal curcumin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call